Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe.

MLA

Lebon, Wilfried, et al. “Efficacy of Two Formulations of Afoxolaner (NexGard® and NexGard Spectra®) for the Treatment of Generalised Demodicosis in Dogs, in Veterinary Dermatology Referral Centers in Europe.” Parasites & Vectors, vol. 11, no. 1, Sept. 2018, p. 506. EBSCOhost, https://doi.org/10.1186/s13071-018-3083-2.

APA

Lebon, W., Beccati, M., Bourdeau, P., Brement, T., Bruet, V., Cekiera, A., Crosaz, O., Darmon, C., Guillot, J., Mosca, M., Pin, D., Popiel, J., Pomorska Handwerker, D., Larsen, D., Tielemans, E., Beugnet, F., & Halos, L. (2018). Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe. Parasites & Vectors, 11(1), 506. https://doi.org/10.1186/s13071-018-3083-2

Chicago

Lebon, Wilfried, Massimo Beccati, Patrick Bourdeau, Thomas Brement, Vincent Bruet, Agnieszka Cekiera, Odile Crosaz, et al. 2018. “Efficacy of Two Formulations of Afoxolaner (NexGard® and NexGard Spectra®) for the Treatment of Generalised Demodicosis in Dogs, in Veterinary Dermatology Referral Centers in Europe.” Parasites & Vectors 11 (1): 506. doi:10.1186/s13071-018-3083-2.